CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Alternate day fastingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02673515
NCT02673515N/ACompleted
CompareCT.gov

The Impact of Intermittent Fasting on Human Metabolism and Cell Autophagy

Medical University of Graz·interventional·Posted Feb 4, 2016·Updated May 28, 2020

In Brief

A clinical study evaluating Alternate day fasting for Excessive Diet Restriction. Completed, enrolled 60 participants across 1 site.

Detailed Summary

InterFast is a Cohort study with an embedded randomized controlled pilot trial. Study participants will be healthy subjects and subjects who already practice Alternate Day Fasting. The trial will include 100 participants (50 Participants in Alternate Day Fasting group and 50 participants in the control group). Those participants in the control group will be asked to participate in a short randomized controlled trial, where they will be either allocated to an Alternative Day Fasting group or another control visit.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsExcessive Diet Restriction
CountriesAustria
CollaboratorsUniversity of Graz

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 4, 2016
Enrollment StartApr 1, 2015
Primary CompletionSep 2, 2019
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 10.4 years ago

Interventions

Alternate day fastingbehavioral

Subjects are requested to fast every other day. Calorie free fluids are allowed.